Most cases of Parkinson’s disease are not directly inherited. Only about 10 to 15 percent of people with Parkinson’s carry a known genetic mutation linked to the disease, and even among those who do, the mutation alone is often not enough to cause symptoms. For the vast majority of patients, the disease arises from a combination of genetic susceptibility and environmental exposures that accumulate over a lifetime.
That said, having a close relative with Parkinson’s does raise your risk. Understanding how much, and why, requires looking at the specific genes involved and how they interact with the world around you.
How Much Does Family History Raise Your Risk?
First-degree relatives of someone with Parkinson’s (children, siblings, or parents) are roughly 2.3 times more likely to develop the disease than people without that family connection. That sounds significant, but the absolute numbers tell a more reassuring story: by age 75, about 2 percent of first-degree relatives of Parkinson’s patients had developed the disease, compared with 1 percent of relatives of people without Parkinson’s. So your baseline risk is low, and doubling a small number still gives you a small number.
This elevated risk applies whether the affected family member has a known genetic mutation or not. Even in “sporadic” cases with no clear family pattern, relatives still face a slightly higher chance, suggesting that subtle genetic factors are at play in most forms of the disease.
The Genes That Matter Most
Several genes have been clearly linked to Parkinson’s, but two stand out because of how common they are.
LRRK2
The LRRK2 gene, specifically a mutation called G2019S, is the most frequently identified genetic change in Parkinson’s patients. It follows a dominant inheritance pattern, meaning you only need one copy from one parent to carry the risk. Each child of someone with this mutation has a 50 percent chance of inheriting it.
But inheriting the mutation doesn’t guarantee you’ll get the disease. Penetrance (the likelihood that a carrier actually develops symptoms) is incomplete. By age 80, roughly 25 to 42 percent of carriers develop Parkinson’s, depending on the population studied. That means more than half of carriers never develop the disease at all.
LRRK2 G2019S is far more common in certain ethnic groups. Among Ashkenazi Jewish Parkinson’s patients, 14 to 19 percent carry this mutation. Among North African Berbers with Parkinson’s, the rate reaches nearly 40 percent. In the general Parkinson’s population, the figure is closer to 1 percent for sporadic cases and 4 percent for familial cases.
GBA
Mutations in the GBA gene are the single most important genetic risk factor for Parkinson’s overall, found in 5 to 15 percent of patients. Unlike LRRK2, GBA mutations don’t cause Parkinson’s in a predictable inheritance pattern. Instead, they act as a risk multiplier, increasing the odds of developing the disease by 5 to 30 times, depending on your age, ethnicity, and the specific mutation involved. Most people with a GBA mutation will never develop Parkinson’s, but the elevated risk is substantial enough that researchers and clinicians pay close attention to it.
Age of Onset Changes the Genetic Picture
The younger someone is when Parkinson’s symptoms appear, the more likely a genetic mutation is involved. A large study of 953 patients diagnosed before age 51 found that 16.6 percent carried a known mutation. But within that group, the numbers varied dramatically by age:
- Diagnosed before age 20: 65 percent had a known genetic mutation
- Ages 21 to 30: 32 percent
- Ages 31 to 40: 16 percent
- Ages 41 to 50: 14 percent
For the typical Parkinson’s patient diagnosed after 60, the probability of carrying a single causative mutation is much lower. This is one reason genetic testing is most often recommended for people with early-onset disease, particularly those diagnosed before 50.
Genes and Environment Work Together
For most people, Parkinson’s isn’t a purely genetic disease or a purely environmental one. It’s both. Pesticide exposure is one of the best-studied environmental triggers, and research shows it can interact directly with genetic vulnerability. People who carry certain gene variants involved in detoxifying chemicals in the brain may be more sensitive to herbicide exposure, potentially influencing when symptoms first appear.
The LRRK2 G2019S mutation, for example, changes how certain protective genes are activated in brain cells, potentially making dopamine-producing neurons more vulnerable to environmental toxins like pesticides. This could help explain why some carriers of the mutation develop Parkinson’s and others don’t: differences in lifetime chemical exposure may tip the balance.
Animal studies have shown that exposure to pesticides like rotenone, paraquat, and dieldrin can alter the chemical “switches” that control gene activity in dopamine-producing neurons. Early-life pesticide exposure in animal models even produced changes in genes critical for maintaining those neurons, and some of these changes carried over to offspring, suggesting environmental exposures in one generation could subtly affect the next.
Who Should Consider Genetic Testing
Genetic testing for Parkinson’s is not routine for every patient. European clinical guidelines recommend it on a case-by-case basis, weighing family history and age of onset. In general, testing is most useful for:
- People diagnosed before age 50, whether or not they have a family history
- People with multiple affected relatives across more than one generation
- People of Ashkenazi Jewish or North African Berber descent, where specific founder mutations are much more common
For someone diagnosed after 60 with no family history, testing is less likely to find a clear genetic cause. The most commonly tested genes include LRRK2 and GBA for typical late-onset cases, and a group of recessive genes (PRKN, PINK1, and DJ-1) for early-onset patients, since mutations in these require copies from both parents and tend to cause disease at younger ages.
If you’re an unaffected relative of someone with Parkinson’s, current guidelines generally offer reassurance. Because the most common genetic risk factors (GBA and LRRK2) have low penetrance, most carriers will not develop the disease. Genetic counseling can help you interpret results and weigh whether testing is worthwhile for your situation, especially since a positive result carries psychological weight but limited options for prevention at this point.